[Idiopathic and secondary membranous nephropathies]. 
Antibodies to neutral endopeptidase, a podocyte protein, are responsible for rare alloimmune neonatal membranous nephropathy that develops in children from neutral endopeptidase-deficient mothers.  Neutral endopeptidase was the first podocyte antigen described in human membranous nephropathy.  PLA2R1, the type-M receptor of soluble phospholipase A2, is a major target antigen in so-called idiopathic membranous nephropathy in adults.  Antibodies to PLA2R1 are detected in 60 to 80% of patients before immunosuppressive treatment, and are only occasionally found in secondary membranous nephropathy.  To date, they have not been detected in other pathological conditions and in healthy individuals.  PLA2R1 and HLA-DQA1 gene variants defined by single nucleotide polymorphisms are strongly associated with idiopathic membranous nephropathy in patients of white ancestry, and can thus be considered as predisposing genes.  In addition to their diagnostic value, anti-PLA2R1 antibodies can be used to monitor treatment.  Immunization against cationic bovine serum albumin is a cause of early childhood membranous nephropathy.  This finding points to a possible role of food and environmental antigens in membranous nephropathy.  The newly identified antigen-antibody systems should be considered as molecular signatures challenging the uniform histological definition and having a major impact on patient care in a near future.